Callahan Advisors buys $1,359,456 stake in Danaher Corporation (DHR)

Danaher Corporation (DHR) : Callahan Advisors scooped up 3,075 additional shares in Danaher Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 14, 2016. The investment management firm now holds a total of 17,850 shares of Danaher Corporation which is valued at $1,359,456.Danaher Corporation makes up approximately 0.35% of Callahan Advisors’s portfolio.

Other Hedge Funds, Including , Nisa Investment Advisors reduced its stake in DHR by selling 1,750 shares or 0.79% in the most recent quarter. The Hedge Fund company now holds 219,907 shares of DHR which is valued at $16,787,700. Danaher Corporation makes up approx 0.22% of Nisa Investment Advisors’s portfolio.Headinvest reduced its stake in DHR by selling 1,875 shares or 2.74% in the most recent quarter. The Hedge Fund company now holds 66,529 shares of DHR which is valued at $5,203,898. Danaher Corporation makes up approx 1.85% of Headinvest’s portfolio.Raymond James Trust N.a. boosted its stake in DHR in the latest quarter, The investment management firm added 147 additional shares and now holds a total of 6,884 shares of Danaher Corporation which is valued at $538,466. Danaher Corporation makes up approx 0.05% of Raymond James Trust N.a.’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in DHR by selling 15,392 shares or 7.17% in the most recent quarter. The Hedge Fund company now holds 199,324 shares of DHR which is valued at $15,503,421. Danaher Corporation makes up approx 0.06% of Bnp Paribas Arbitrage Sa’s portfolio.

Danaher Corporation closed down -0.05 points or -0.07% at $76.16 with 32,21,072 shares getting traded on Friday. Post opening the session at $76.76, the shares hit an intraday low of $76.04 and an intraday high of $76.8 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.